Preparation and Characterization of Theophylline Controlled Release Matrix System Incorporating Poloxamer 407, Stearyl Alcohol, and Hydroxypropyl Methylcellulose: A Novel Formulation and Development Study
Polymers · 27.02.2024 · 16 (5) · 643
DOI: 10.3390/polym16050643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers, online erschienen am 27.02.2024. Verfasst von Molham Sakkal und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al Ain University of Science and Technology, United Arab Emirates University, Al Ain University.
Abstract (Originalsprache)
Background
Theophylline (THN), a bronchodilator with potential applications in emerging conditions like COVID-19, requires a controlled-release delivery system due to its narrow therapeutic range and short half-life. This need is particularly crucial as some existing formulations demonstrate impaired functionality. This study aims to develop a new 12-h controlled-release matrix system (CRMS) in the form of a capsule to optimize dosing intervals.
Methods
CRMSs were developed using varying proportions of poloxamer 407 (P-407), stearyl alcohol (STA), and hydroxypropyl methylcellulose (HPMC) through the fusion technique. Their in vitro dissolution profiles were then compared with an FDA-approved THN drug across different pH media. The candidate formulation underwent characterization using X-ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. Additionally, a comprehensive stability study was conducted.
Results
In vitro studies showed that adjusting the concentrations of excipients effectively controlled drug release. Notably, the CRMS formulation 15 (CRMS-F15), which was composed of 30% P-407, 30% STA, and 10% HPMC, closely matched the 12 h controlled-release profile of an FDA-approved drug across various pH media. Characterization techniques verified the successful dispersion of the drug within the matrix. Furthermore, CRMS-F15 maintained a consistent controlled drug release and demonstrated stability under a range of storage conditions.
Conclusions
The newly developed CRMS-F15 achieved a 12 h controlled release, comparable to its FDA-approved counterpart.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.
- Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
- Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
ORCID-Profile: Molham Sakkal, Mosab Arafat, Priya Yuvaraju
Förderung
- Al Ain University of Science and Technology
- United Arab Emirates University
- Al Ain University
Zitieren
APA
Sakkal, M., Arafat, M., Yuvaraju, P., Beiram, R., & AbuRuz, S. (2024). Preparation and Characterization of Theophylline Controlled Release Matrix System Incorporating Poloxamer 407, Stearyl Alcohol, and Hydroxypropyl Methylcellulose: A Novel Formulation and Development Study. Polymers, 16(5), 643. https://doi.org/10.3390/polym16050643
Vancouver
Sakkal M, Arafat M, Yuvaraju P, Beiram R, AbuRuz S. Preparation and Characterization of Theophylline Controlled Release Matrix System Incorporating Poloxamer 407, Stearyl Alcohol, and Hydroxypropyl Methylcellulose: A Novel Formulation and Development Study. Polymers. 2024;16(5):643. doi:10.3390/polym16050643
BibTeX
@article{Sakkal2024,
author = {Sakkal, Molham and Arafat, Mosab and Yuvaraju, Priya and Beiram, Rami and AbuRuz, Salahdein},
title = {Preparation and Characterization of Theophylline Controlled Release Matrix System Incorporating Poloxamer 407, Stearyl Alcohol, and Hydroxypropyl Methylcellulose: A Novel Formulation and Development Study},
journal = {Polymers},
year = {2024},
volume = {16},
number = {5},
pages = {643},
doi = {10.3390/polym16050643}
}
EUVIMED